These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5050169)

  • 1. [Effect of a new enzymatic complex with elastolytic action in clinical arteriosclerosis].
    Pretolani E; Coccheri S; De Rosa V; Addarii F
    Boll Soc Ital Biol Sper; 1972 Apr; 48(7):174-6. PubMed ID: 5050169
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral aspects of a new enzymatic complex with elastolytic action in experimental arteriosclerosis].
    Coccheri S; De Rosa V; Pretolani E; Zoli I
    Boll Soc Ital Biol Sper; 1972 Apr; 48(7):171-3. PubMed ID: 5050167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parietal elastolytic activity and histological changes caused by a new enzymatic complex with elastolytic action in experimental arteriosclerosis].
    Coccheri S; Pretolani E; Addarii F; Zoli I
    Boll Soc Ital Biol Sper; 1972 Apr; 48(7):173-4. PubMed ID: 5050168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of glutathione on the development of atherosclerosis and on blood coagulation].
    Ol'shanskiĭ ChS; Khanin AL
    Patol Fiziol Eksp Ter; 1974; (1):82-5. PubMed ID: 4459793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antilipemic and fibrinolytic activity of an extractive mucopolysaccharide in atherosclerotic disease].
    Isidori A; Butti A; Rossi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5077-81. PubMed ID: 4188592
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of clofibrate in hypercholesterinemic rabbits and in arteriosclerotic subjects-modifications of platelet aggregation and fibrinolysis as related to lipidic fractions.
    Baldoni F; Egge H; Giarola P; Müller H; Cuttin S; Gibelli A; Zilliken F; de Nicola P
    New Istanbul Contrib Clin Sci; 1972 Dec; 10(3):135-8. PubMed ID: 4670445
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on decrease of serum lipids and acceleration of fibrinolysis induced by phosphatidyl choline].
    Matsuo T; Yoshida M; Ishihama Y; Imamura H; Fukuzaki H
    Naika Hokan; 1971 Sep; 18(9):355-60. PubMed ID: 5169518
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of hexoprenaline (ST 1512, Ipradol) on blood coagulation and fibrinolysis].
    Fischer M
    Wien Klin Wochenschr; 1971 Feb; 83(8):130-4. PubMed ID: 5545655
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclonamine ethamsilate in the treatment of atherosclerotic vascular diseases in the senile age, with spcial reference to the blood lipid level].
    Volterrani U; Baiotti G
    Minerva Med; 1970 Nov; 61(91):5185-94. PubMed ID: 5496158
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I].
    Cajozzo A; Citarrella P; Malleo C
    Boll Soc Ital Cardiol; 1971; 16(3):117-26. PubMed ID: 4110180
    [No Abstract]   [Full Text] [Related]  

  • 13. [A biophysical study of antisclerotic agents--longterm effect of elastase as measured by aortic pulse wave velocity method].
    Hasegawa M; Arai C; Abe N; Takeuchi K; Fukunaga Y; Manaumi H; Takayama Y; Emori I; Kishi Y
    Nihon Ronen Igakkai Zasshi; 1984 Mar; 21(2):115-23. PubMed ID: 6566713
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of drug preparations used in treating coronary arteriosclerosis on the coagulogram and blood biochemical indices].
    Semavin IE; Goliakov VN; Semiletov VI; Solov'ev VV
    Sov Med; 1979 Jan; (1):31-5. PubMed ID: 424857
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypotensive effects and influence on serum lipids of SQ29,852, a new angiotensin converting enzyme inhibitor, in patients with essential hypertension: a comparison with atenolol.
    Sasaki J; Koga S; Kato K; Takii M; Sakai K; Kawasaki K; Kagimoto M; Doi Y; Takada K; Sakaue A
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):83-8. PubMed ID: 8458681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities of the overlapping of fibrinolytic and elastolytic activity in experimental cholesterine atherosclerosis].
    Pretolani E; Loreti A; Foschi V
    Arzneimittelforschung; 1967 Aug; 17(8):986-91. PubMed ID: 5632074
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estrogen and arteriosclerosis].
    Murakami M
    Nihon Naibunpi Gakkai Zasshi; 1967 Sep; 43(6):454-9. PubMed ID: 5626190
    [No Abstract]   [Full Text] [Related]  

  • 19. [Human adrenoreactive systems of different types].
    Kulinskiĭ VI; Kulinskaia IL; Chesmochakova EI
    Biull Eksp Biol Med; 1980 Oct; 90(10):395-7. PubMed ID: 7426697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of iodine on the blood coagulation, anticoagulation and fibrinolytic systems in patients with atherosclerosis].
    Shershevskiĭ MG; Rassokhin VM
    Kardiologiia; 1966; 6(1):74-7. PubMed ID: 5970414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.